Conference: Gene Therapy for Rare Disorders, 2024

Conference: Gene Therapy for Rare Disorders

Project Farma and Precision will be at this year’s Gene Therapy for Rare Disorders conference March 26 – 29 in Boston, MA. Connect with our team of experts as they participate in meaningful presentations and discussions throughout the event providing insights into the clinical development, manufacturing, and commercialization for advanced therapies. This year, the Precision team is hosting an exciting Plenary Session on Day One and a Chair Track Session on Day Two. Connect with our Advanced Therapy experts in the exhibition area!

Plenary Session Title: What to Look Forward to for Gene Therapy in 2024​ | Wednesday, March 27th | 8:30am EST


  • Market trends and expectations for Gene Therapies & Rare Diseases in 2024​
  • Predictions on Potential Approvals in 2024​
  • Innovative Trends & Technologies​
  • Evolution of CMC and manufacturing


  • [Moderator] Jacob Greenwood, Vice President, Strategy (Project Farma)
  • Faraz Ali, Chief Executive Officer (Tenaya Therapeutics)
  • Frank Bugg, Global Head of BaseCamp Operations & Commercial (ElevateBio)
  • Debs Phippard, Chief Scientific Officer (Precision for Medicine)

Chair Track Session: Clinical Endpoints for Rare Disease Studies | Thursday, March 28th | 11:15 – 12:15pm EST

Andy Kinley, Vice President, Innovation and Clinical Science (Precision for Medicine) will chair the ‘Clinical Endpoints for Rare Disease Studies’ session.  

Click here to learn more!